DarioHealth Corp.

5.31+0.1000+1.92%Vol 1.77M1Y Perf -76.91%
Jun 24th, 2022 16:00 DELAYED
BID5.00 ASK5.49
Open5.30 Previous Close5.21
Pre-Market- After-Market5.49
 - -  0.18 3.39%
Target Price
18.15 
Analyst Rating
Strong Buy 1.00
Potential %
241.81 
Finscreener Ranking
★★★★★     63.13
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
★★★★     55.02
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★★★★+     62.39
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
6.09 
Earnings Rating
Sell
Market Cap116.75M 
Earnings Date
15th Aug 2022
Alpha-0.02 Standard Deviation0.25
Beta1.35 

Today's Price Range

5.085.33

52W Range

4.1123.80

5 Year PE Ratio Range

-2.50-1.20

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-2.75%
1 Month
-15.71%
3 Months
-13.52%
6 Months
-61.10%
1 Year
-76.91%
3 Years
-46.90%
5 Years
-87.82%
10 Years
-

TickerPriceChg.Chg.%
DRIO5.310.10001.92
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
4.80
5.40
0.00
0.00
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
27.50
-312.40
-296.80
-305.20
-
RevenueValueIndustryS&P 500US Markets
24.98M
1.14
38.34
35.42
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.98-0.7424.49
Q04 2021-1.13-1.093.54
Q03 2021-0.95-1.18-24.21
Q02 2021-0.84-0.99-17.86
Q01 2021-0.93-0.921.08
Q04 2020-0.62-1.06-70.97
Q03 2020-0.84-0.7115.48
Q02 2020-1.74-0.6761.49
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.7717.20Positive
9/2022 QR-0.834.60Positive
12/2022 FY-3.1113.85Positive
12/2023 FY-1.7539.45Positive
Next Report Date15th Aug 2022
Estimated EPS Next Report-0.77
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume1.77M
Shares Outstanding21.99K
Shares Float14.90M
Trades Count5.99K
Dollar Volume9.32M
Avg. Volume329.69K
Avg. Weekly Volume467.80K
Avg. Monthly Volume263.45K
Avg. Quarterly Volume257.84K

DarioHealth Corp. (NASDAQ: DRIO) stock closed at 5.31 per share at the end of the most recent trading day (a 1.92% change compared to the prior day closing price) with a volume of 1.77M shares and market capitalization of 116.75M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 72 people. DarioHealth Corp. CEO is Erez Raphael.

The one-year performance of DarioHealth Corp. stock is -76.91%, while year-to-date (YTD) performance is -59.06%. DRIO stock has a five-year performance of -87.82%. Its 52-week range is between 4.11 and 23.7999, which gives DRIO stock a 52-week price range ratio of 6.09%

DarioHealth Corp. currently has a PE ratio of -1.40, a price-to-book (PB) ratio of 1.05, a price-to-sale (PS) ratio of 4.81, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -65.10%, a ROC of -70.12% and a ROE of -72.32%. The company’s profit margin is -%, its EBITDA margin is -296.80%, and its revenue ttm is $24.98 Million , which makes it $1.14 revenue per share.

Of the last four earnings reports from DarioHealth Corp., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.77 for the next earnings report. DarioHealth Corp.’s next earnings report date is 15th Aug 2022.

The consensus rating of Wall Street analysts for DarioHealth Corp. is Strong Buy (1), with a target price of $18.15, which is +241.81% compared to the current price. The earnings rating for DarioHealth Corp. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DarioHealth Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DarioHealth Corp. has a Sell technical analysis rating based on Technical Indicators (ADX : 21.91, ATR14 : 0.54, CCI20 : -126.90, Chaikin Money Flow : 0.02, MACD : -0.22, Money Flow Index : 47.21, ROC : -26.56, RSI : 38.80, STOCH (14,3) : 9.16, STOCH RSI : 0.25, UO : 36.94, Williams %R : -90.84), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DarioHealth Corp. in the last 12-months were: Dror Bacher (Sold 27 083 shares of value $537 232 ), Erez Raphael (Sold 109 023 shares of value $2 023 474 ), Oded Cohen (Sold 20 000 shares of value $322 200 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

DarioHealth Corp.

DarioHealth Corp is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue by sales of its product.

CEO: Erez Raphael

Telephone: +972 47704055

Address: 8 HaTokhen Street, Caesarea 3088900, , IL

Number of employees: 72

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

58%42%

Bearish Bullish

55%45%

TipRanks News for DRIO

News

Stocktwits